A PI-RADS 4 result means your prostate MRI found a lesion that is moderately suspicious for clinically significant prostate cancer. The scale runs from 1 to 5. A score of 4 sits on the suspicious side of the line, and it usually leads to a biopsy. It does not mean you have cancer. It means the MRI found something that needs a tissue sample to settle the question.
What Does A Pi Rads 4 Prostate Mri Result Mean?
PI-RADS stands for Prostate Imaging Reporting and Data System. It is a standardized way for radiologists to describe what they see on a multiparametric MRI of the prostate. The system was created so that a scan read in one hospital means the same thing as a scan read in another.
A score of 4 means the radiologist judges the chance of a clinically significant cancer to be moderate. That phrase matters. Clinically significant generally means a cancer that is likely to cause harm if left alone, as opposed to a small, low-grade tumor that may never cause problems.
Here is the non-obvious part many people miss. PI-RADS is not a cancer probability score in the way a percentage is. It is a structured judgment based on how tissue looks on different MRI sequences. The same score of 4 can come from different features in different men. That is why your urologist looks at the actual images and the written description, not just the number.
The most recent version of the system, PI-RADS v2.1, is the version most radiology departments currently use. If your report says “v2.1,” that tells you which set of rules the radiologist applied.
What Are The Pi Rads Scores And Where Does 4 Fit?
The scale has five levels. Each one describes how likely a lesion is to be a clinically significant cancer.
- PI-RADS 1: Very low suspicion. Clinically significant cancer is highly unlikely.
- PI-RADS 2: Low suspicion. Clinically significant cancer is unlikely.
- PI-RADS 3: Equivocal. The presence of clinically significant cancer is uncertain.
- PI-RADS 4: High suspicion. Clinically significant cancer is likely.
- PI-RADS 5: Very high suspicion. Clinically significant cancer is highly likely.
The wording above reflects how the system frames each category. Notice that 3 is the true middle ground. A 3 is genuinely ambiguous, and clinicians often debate whether biopsy is needed. A 4 is not ambiguous in the same way. It leans clearly toward suspicion.
One practical point: the score describes a specific lesion, not your whole prostate. A report can list several findings with different scores. The highest score usually drives the next step.
How Likely Is Cancer With A Pi Rads 4 Score?
Men with a PI-RADS 4 lesion are more likely than not to have clinically significant cancer found on biopsy. That is the plain reading of the category. But the exact rate varies a lot between studies and between patient groups.
I am not going to give you a precise percentage, because the figures reported across the literature range widely and depend on the population studied, the MRI technique, and how the biopsy was done. Quoting one number would suggest a precision that does not exist.
What is well established is the direction. Higher PI-RADS scores track with higher rates of clinically significant cancer on biopsy. A 4 carries substantially more risk than a 3, and a 5 carries more than a 4. This pattern is consistent across research.
Several factors shift your personal odds:
- Your PSA level and how fast it has changed
- Your age and family history
- Whether you have had a prior negative biopsy
- The size and location of the lesion
- The experience of the radiologist reading the scan
A PI-RADS 4 combined with a high or rising PSA is a different situation than a PI-RADS 4 with a borderline PSA. Your urologist weighs these together.
Does A Pi Rads 4 Result Always Mean A Biopsy?
In most cases, yes. A PI-RADS 4 finding is generally an indication for prostate biopsy. This is the standard clinical pathway, and it reflects the moderate-to-high suspicion the score represents.
Biopsy is how the question gets answered. MRI shows how tissue looks. Only a tissue sample shows what the cells actually are. No imaging score can substitute for that.
The usual approach is a targeted biopsy, often combined with systematic sampling. The MRI images guide the needle toward the specific lesion, which improves the chance of sampling the right area. This is one of the main reasons MRI is done before biopsy rather than after.
There are situations where the conversation is more nuanced. Some men with significant other health problems, or those for whom treatment would not change, may discuss the risks and benefits of biopsy more carefully with their doctor. Some clinicians also use additional risk calculators or biomarkers to refine the decision. These are judgment calls made with your care team, not rules.
What I would not do is assume a 4 can be safely ignored because you feel fine. Early prostate cancer usually causes no symptoms at all. Feeling well is not evidence against it.
What Happens During And After A Prostate Biopsy?
A prostate biopsy is typically done in an office or clinic setting. A thin needle is passed through the wall of the rectum or through the perineum, the skin between the scrotum and anus, to reach the prostate. Most men receive local numbing, and many receive sedation or pain medication.
You will usually be given antibiotics around the procedure to reduce the risk of infection. This is standard practice, and it is one of the reasons you should tell your doctor about any antibiotic allergies beforehand.
Common after-effects include:
- Blood in the urine for a few days
- Blood in the semen, which can last for several weeks
- Some discomfort or soreness
- Light bleeding from the rectum if that route was used
These are expected and usually settle on their own. Call your doctor promptly for fever, chills, difficulty urinating, or worsening pain. Infection after biopsy is uncommon but serious, and it needs treatment quickly.
Results typically come back within a week or two, depending on the lab. If cancer is found, the pathologist assigns a Gleason score or a Grade Group, which describes how aggressive the cells look. That grade, combined with your PSA and the number of biopsy samples involved, shapes the treatment discussion far more than the MRI score alone.
What If The Biopsy Finds Nothing?
A negative biopsy after a PI-RADS 4 result does not always close the case. Sometimes the needle simply misses the lesion, especially if it sits in a hard-to-reach part of the prostate. This is called a false negative, and it is a recognized limitation of biopsy.
Your urologist may recommend repeat testing, a repeat biopsy, or ongoing PSA monitoring depending on your situation. Some men are watched with serial PSA tests and follow-up imaging rather than immediate repeat biopsy. The right path depends on your individual risk.
It is also possible for a biopsy to find cancer that is low-grade and unlikely to cause harm. In that case, active surveillance is often discussed. That means regular monitoring rather than immediate treatment. This is a well-established approach for low-risk prostate cancer, though whether it fits your situation is a decision for you and your specialist.
What Should You Do With A Pi Rads 4 Result?
Get a clear explanation of the report from the doctor who ordered the MRI. Ask which lesion scored a 4, where it is, and what the radiologist described. Ask how the score fits with your PSA history.
Then have a real conversation about biopsy, including the risks, the alternatives, and what the results would change. Bring your questions in writing. It is easy to forget them in the moment.
A PI-RADS 4 is a signal to act on, not a diagnosis. It means the imaging found something worth investigating properly. The next step is almost always a tissue sample, and the answer it provides is what actually guides your care.
Frequently Asked Questions
What percentage of PI-RADS 4 lesions are cancer?
Reported rates vary widely across studies, so no single reliable percentage applies to everyone. What is consistent is that PI-RADS 4 carries a meaningfully higher chance of clinically significant cancer than a score of 3.
Can a PI-RADS 4 be benign?
Yes. Some PI-RADS 4 lesions turn out to be benign on biopsy, such as inflammation or benign prostate tissue. That is exactly why biopsy is recommended rather than assuming cancer.
Is PI-RADS 4 considered early stage cancer?
PI-RADS 4 is not a cancer stage at all. It is a suspicion score from imaging, and staging only happens after cancer is confirmed and graded on biopsy.
Should I wait and repeat the MRI instead of having a biopsy?
That decision belongs to you and your urologist, because the trade-offs differ from person to person. In general, a PI-RADS 4 is treated as a reason to sample the tissue rather than to wait.

